New patent for drug Azurity FIRVANQ KIT – DrugPatentWatch
Annual Drug Patent Expiration for FIRVANQ+KIT
Firvanq Kit is a drug marketed by Azurity and included in one NDA. It is available from two suppliers. There are six patents protecting this drug.
Drug patent litigation for FIRVANQ KIT.
This drug has nine patent family members in seven countries.
The generic ingredients in the FIRVANQ KIT are vancomycin hydrochloride. Two registered suppliers for this compound. Additional details are available on the vancomycin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Azurity FIRVANQ KIT
